Abstract The American Thoracic Society, Centers for Disease Control and Prevention, and
Infectious Diseases Society of America jointly sponsored the development of this guideline …

Importance New data and therapeutic options warrant updated recommendations for the use
of antiretroviral drugs (ARVs) to treat or to prevent HIV infection in adults. Objective To …

Tuberculosis (TB) has recently surpassed HIV as the primary infectious disease killer
worldwide, but the two diseases continue to display lethal synergy. The burden of TB is …

Introduction: Antiretroviral and anti-tuberculosis (TB) drugs are often co-administered in
people living with HIV (PLWH). Early initiation of antiretroviral therapy (ART) during TB …

Importance New data and antiretroviral regimens expand treatment choices in resource-rich
settings and warrant an update of recommendations to treat adults infected with human …

About one fourth of the world's population is estimated to be infected with M. tuberculosis (1,
2). The risk of TB disease after infection depends on several factors, the most important …

In Deutschland ist seit 2015 ein deutlicher Anstieg der gemeldeten Tuberkulosefälle zu
verzeichnen. Zurückzuführen ist dieser vor allem auf die aktuell vermehrte Migration. Durch …

Background The week 48 primary analysis of the ENCORE1 trial established the virological
non-inferiority and safety of efavirenz 400 mg compared with the standard 600 mg dose …

The overall purpose of these guidelines is to provide guidance on best clinical practice in
the treatment and management of adults with HIV infection on antiretroviral therapy (ART) …

Background. Concomitant use of rifamycins to treat or prevent tuberculosis can result in
subtherapeutic concentrations of antiretroviral drugs. We studied the interaction of efavirenz …